Quality of life before and during antihypertensive treatment: A comparative study of celiprolol and atenolol

American Journal of Therapeutics

Volumn 4, Issue 4, 1997, Pages 117-122

  Cleophas, Ton J M ^a   Mey, Nynke V D ^b   Meulen, Jan V D ^a   Niemeyer, Menco G ^c  

^a Merwede Ziekenhuis   (Netherlands)

^b Med Dept Rhone Poulenc Rorer Inc   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Atenolol; Celiprolol; Hypertension; Parallel group trial; Quality of life

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELIPROLOL; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

EID: 0030962839     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-199704000-00002     Document Type: Article

References (19)

1. Jachuck SJ, Brierley H, Jachuck S, Willcox PM: The effects of hypertensive drugs on quality of life. J Coll Gen Pract 1982;32:103-105.
2. Croog SH, Levine S, Testa MA: The effects of anti-hypertensive therapy on quality of life. N Engl J Med 1986;314:1657-1664.
3. Materson BJ, Reda DJ, Cushman WC: Single-drug therapy for hypertension in men - a comparison of six anti-hypertensive agents with placebo. N Engl J Med 1993;328:914-921.
4. Applegate WB, Phillips HL, Schnaper H: A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 1991;151:1817-1823.
5. Cleophas TJM, van 't Leven M, Kauw FHW, et al: Celiprolol vs propranolol in unstable angina pectoris. Clin Pharmacol Ther 1995;57:67-72.
6. Dunn CJ, Spencer CM: Celiprolol, an evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris. Drugs Aging 1995;7:394-411.
7. Joint National Committee on Detection: Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-183.
8. Bulpitt CJ, Fletcher AE: The measurement of quality of life in hypertensive patients: a practical approach. Br J Clin Pharmacol 1990;30:353-364.
9. De Diana IPF: Two stochastic sleep quality scales for self-rating of subject's sleep. Sleep Res 1976;5:101-105.
10. McNair DM, Lore M, Droppleman RF (eds): Manual for the Profile of Mood States (POMS). San Diego: Educational And Industrial Testing Service, 1971.
11. Wald FDM, Mellenberg GJ: De verkorte versie van de Nederlandse vertaling van de Profile of Mood States (POMS). Ned Tijdschr Psych 1990;45:86-90.
12. Andrews FM, Withey SB: Social Indicators of Well-being. American Perception of Life Quality. New York: Plenum Press, 1987.
13. Benet LZ: Patient compliance instructions. In: Goodman & Gilman's Pharmacological Basis of Therapeutics (Eds. Gilman A, Rall TW, Nies A, Taylor P). New York: Pergamon Press, 1991, pp. 1647-1649.
14. Gill TM, Feinstein AR: A critical appraisal of the quality of quality-of-life measurements. JAMA 1994;272:619-626.
15. Silke B, Rosenthal I, Taylor S: A randomised double-blind study of atenolol and celiprolol in mild to moderate hypertension. J Cardiovasc Pharmacol 1986;8(Suppl 4):122-126.
16. Dujovne CA, Ett J, Ferraro L: Comparative effects of atenolol versus celiprolol on serum lipids and blood pressure in hyperlipidemic and hypertensive subjects. Am J Cardiol 1993;72:1131-1136.
17. Wilson IB, Cleary PD: Linking clinical variables with health-related quality of life. JAMA 1995;273:59-65.
18. Meenan RM, Anderson JJ, Kuzis LE: Outcome assessment in clinical trials: evidence for the sensitivity of a health status measure. Arthritis Rheum 1984;27:1344-1351.
19. Laupacis A, Wong C, Churchill D: The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. Control Clin Trials 1991;12:168-179.